Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

The FDA has given an accelerated approval for a new protease inhibitor (PI) for the treatment of HIV infections. Darunavir (TMC114) is approved for patients who have shown resistance to more than one protease inhibitor.

Darunavir Tablets (Prezista™)